DAMON SUTTLE: Open Payments
NPI 1821786393 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 82 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,764 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 21 | $313 |
| Amgen Inc. | 18 | $211 |
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| Exact Sciences Corporation | 6 | $101 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Novo Nordisk Inc | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
Products named: TRELEGY ELLIPTA, OTEZLA, AIRSUPRA, Cologuard Collection Kit, SHINGRIX, CAPLYTA, FARXIGA, VOQUEZNA.
Industry payments across AZ — which companies pay providers there.
